Children's Hospital is part of the UPMC family.
The Norditropin® National Registry is a multi-center, open-label, post-marketing surveillance study available to all patients being treated with Norditropin for growth failure associated with an inadequate secretion of growth hormone. Norditropin is a human growth hormone made by recombinant DNA technology. The primary objective of this protocol is to collect information on the long-term safety, growth and pharmo-dynamic response of Norditropin as used in clinical practice in the United States.
Children of either sex who are being treated with Norditropin for growth failure are eligible to participate.
Boys: All ages
Girls: All ages
Participation will only involve data collection and periodic blood draws, conducted as part of routine patient care. The study will collect and record all medical record information from lab tests, x-rays and clinic visits.
Visits: None beyond normal clinical care
Duration: Until patient is no longer seen in clinic
Novo Nordisk Inc.
Oscar Escobar, MD
To get started, please contact:
Ana Diaz, RN
Virginia Stefanick, RN
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
Children’s Hospital of Pittsburgh of UPMC
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Visit Children's Hospital of Pittsburgh Foundation's website to: